Ontology highlight
ABSTRACT:
SUBMITTER: So L
PROVIDER: S-EPMC4924540 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature
So Lomon L Lee Jongdae J Palafox Miguel M Mallya Sharmila S Woxland Chaz G CG Arguello Meztli M Truitt Morgan L ML Sonenberg Nahum N Ruggero Davide D Fruman David A DA
Science signaling 20160531 430
Rapamycin has been used as a clinical immunosuppressant for many years; however, the molecular basis for its selective effects on lymphocytes remains unclear. We investigated the role of two canonical effectors of the mammalian target of rapamycin (mTOR): ribosomal S6 kinases (S6Ks) and eukaryotic initiation factor 4E (eIF4E)-binding proteins (4E-BPs). S6Ks are thought to regulate cell growth (increase in cell size), and 4E-BPs are thought to control proliferation (increase in cell number), with ...[more]